Dilated cardiomyopathy
Dilated cardiomyopathy is a condition in which the heart muscle becomes thin and enlarged, usually starting in the lower left chamber. The enlarged chamber makes it harder for the heart to pump blood to the rest of the body. Over time the form that has no other cause can develop complications that threaten life, which can include abnormal heart rhythms and heart failure.
Also called DCM
- Condition
- In this atlas
Overview
Technical summary
MeSH descriptor D002311 (Cardiomyopathy, Dilated). The MeSH scope note describes a form of cardiac muscle disease characterized by ventricular dilation, ventricular dysfunction and heart failure. The MedlinePlus Genetics page describes the nonsyndromic form, which cannot be explained by other causes such as a heart attack or valve damage, so its statements on complications may not fit every person with the condition.
Burden
No burden claims are published.
Claims and evidence
Context People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages
- Recipient
- Recipient not specified
- Population
- People with cardiomyopathy in general. The pages are written for the public or as a vocabulary and give no study population. They describe adults and also say that newborns and children can have cardiomyopathy. The MedlinePlus Genetics pages describe the nonsyndromic forms, which are not explained by other causes and do not affect other parts of the body.
- Care setting
- General health information for the public; no care setting is stated
- Geography
- United States (pages of US government agencies); the MeSH vocabulary is international
- Life stage
- Not limited by age. NHLBI says people of any age can have cardiomyopathy, including newborns and children, and names peripartum cardiomyopathy as a form that affects some women around pregnancy.
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (descriptive statement)
Eligibility: inclusion criteria not stated; exclusion criteria not stated
- Included
- None stated
- Excluded
- None stated
The MeSH scope note describes dilated cardiomyopathy as a form of heart muscle disease characterized by ventricular dilation, ventricular dysfunction and heart failure. MedlinePlus Genetics describes the heart muscle as becoming thin and enlarged, with the dilation typically starting in the lower left chamber, which makes it harder for the heart to pump blood to the rest of the body, and says that over time the nonsyndromic form may lead to life-threatening complications that can include abnormal heart rhythms and heart failure.
Applies to Recipient not specified People with cardiomyopathy, as described in MeSH, MedlinePlus, MedlinePlus Genetics and NHLBI reference pages
- Certainty method
- Not assessed
- Limitations
- Vocabulary and patient-education pages from US government sources. The MedlinePlus Genetics page describes the nonsyndromic form, which cannot be explained by other causes such as a heart attack or valve damage, so it may not describe every person with the condition. The pages give no study, no size of risk and no population beyond the general public.
- Last checked
- 2026-10-30
- Next evidence check due
- Not scheduled
Sources and citations (5)
-
Supports MeSH scope note for descriptor D002311 (Cardiomyopathy, Dilated)
- Locator
- scopeNote.@value
- How it applies
- MeSH scope note of the descriptor Cardiomyopathy, Dilated.
- Retrieved
- Source effective date
- Not reported
- Source state
- Current
- Version fingerprint
02148a0db0bf7b6d293f2c7e14336a766fc2a7be259f8a5c19bdbab1a3a6803b- Reuse basis
- The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. This copy was fetched on 2026-10-30 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
-
Supports Nonsyndromic dilated cardiomyopathy (MedlinePlus Genetics)
- Locator
- Description, para 1, sentence 1
- How it applies
- What the condition is.
- Retrieved
- Source effective date
- 2025-11-19
- Source state
- Current
- Version fingerprint
762f70959c269f3e110ec75a949c9f9a1f0da4e2d08708e1c4d59ce6af53e1e4- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Nonsyndromic dilated cardiomyopathy (MedlinePlus Genetics)
- Locator
- Description, para 1, sentence 2 (first part)
- How it applies
- Where the dilation usually starts.
- Retrieved
- Source effective date
- 2025-11-19
- Source state
- Current
- Version fingerprint
762f70959c269f3e110ec75a949c9f9a1f0da4e2d08708e1c4d59ce6af53e1e4- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Nonsyndromic dilated cardiomyopathy (MedlinePlus Genetics)
- Locator
- Description, para 1, sentence 2
- How it applies
- Effect on pumping.
- Retrieved
- Source effective date
- 2025-11-19
- Source state
- Current
- Version fingerprint
762f70959c269f3e110ec75a949c9f9a1f0da4e2d08708e1c4d59ce6af53e1e4- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
-
Supports Nonsyndromic dilated cardiomyopathy (MedlinePlus Genetics)
- Locator
- Description, para 4, sentence 1
- How it applies
- Complications over time.
- Retrieved
- Source effective date
- 2025-11-19
- Source state
- Current
- Version fingerprint
762f70959c269f3e110ec75a949c9f9a1f0da4e2d08708e1c4d59ce6af53e1e4- Reuse basis
- MedlinePlus states that works produced by the federal government are not copyrighted, and lists the summaries on health topic pages and Genetics pages as public domain (the page titled Linking to and Using Content from MedlinePlus, fetched 2026-10-30, sha256 e0fbefd889f779a2537ed84f7649157343e52043a577e2a21ddaf9c416844161). It names the A.D.A.M. encyclopedia, drug monographs and many images as copyrighted; this atlas uses only the page summary text. The raw page is committed in the atlas repository. Terms re-checked on 2026-11-08 at https://medlineplus.gov/about/using/usingcontent/ (page not committed; sha256 0825c88f5bd1dade7c8693bad8035b0d1f25fd0b8c5053e488c618fb2b62e722). That page says health topic page summaries, medical test information and Genetics page summaries are in the public domain, and that A.D.A.M. Medical Encyclopedia content (medlineplus.gov/ency/), ASHP drug monographs and most images are copyrighted. This source is a public-domain page, not an A.D.A.M. page, so public text stays quote; any A.D.A.M. page would be cite_only.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact Risk raised by: Myocarditis
Applies to Recipient not specified People with myocarditis (MeSH scope note and narrative review)
Population, setting and follow-up
- People with inflammation of the heart muscle, from any cause, as the review and the scope note describe them.
- Clinical care of heart muscle disease, as described in the review.
- Not stated for the review as a whole.
- The review says myocarditis occurs more often in males and at a young age; this record does not repeat that. This record makes no statement about pregnancy, newborns or children.
- Gestational age Not reported
- Postnatal age Not reported
MeSH describes myocarditis as inflammatory processes of the muscular walls of the heart that result in injury to the cardiac muscle cells, and as a common cause of dilated cardiomyopathy and other cardiomyopathies. A 2023 narrative review (Biology) says it is an inflammatory disease of the myocardium caused by infectious or non-infectious agents, that it can lead to serious short-term and long-term sequelae such as sudden cardiac death or dilated cardiomyopathy, that its manifestations range from mild symptoms to fulminant presentation with cardiogenic shock, acute heart failure and life-threatening arrhythmias, and that patients with myocarditis can mimic acute myocardial infarction or acute pericarditis at presentation.Limitations. A thesaurus scope note and a narrative review, with no study data, rates or follow-up times. The review's causes, mechanisms, diagnostic tests, prognostic markers and treatments are not repeated, and nothing here is an instruction for diagnosis or care. The review notes that diagnosis is hard and that the evidence for prognosis is limited.
-
Claim, not a settled fact Evaluated for this: Ivabradine
Applies to Child Children aged 6 months and older with stable symptomatic heart failure due to dilated cardiomyopathy, as described in the US label of Corlanor
Population, setting and follow-up
- Pediatric patients aged 6 months and older with stable symptomatic heart failure due to dilated cardiomyopathy who are in sinus rhythm with an elevated heart rate, as the label states.
- Prescription medicine, as described in the US label
- United States (label of the US Food and Drug Administration)
- Pediatric patients aged 6 months and older, as the label states
- Gestational age Not reported
- Postnatal age Not reported
The US label of Corlanor (ivabradine, Amgen Inc, applications NDA206143 and NDA209964; the version dated 2026-11-09 in openFDA) lists the treatment of stable symptomatic heart failure due to dilated cardiomyopathy in pediatric patients aged 6 months and older who are in sinus rhythm with an elevated heart rate.Limitations. This claim records what the label says about pediatric patients. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The adult indication is recorded in a separate claim. The label's pediatric use, dosing and safety sections were not read. openFDA's own disclaimer says not to rely on it for decisions about medical care.
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 15
Record details
- Record id
cardio:dilated-cardiomyopathy- Content hash
c5cf0e903aa3c516bb79462e8ef6ddb8bcc7e24477d091a7c814d433d611c292